Bmw Pharmaco India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 1.00 M
as on 02-07-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.36 Cr
as on 02-07-2024
- Satisfied Charges ₹ 5.74 Cr
as on 02-07-2024
- Revenue -26.31%
(FY 2023)
- Profit -39.64%
(FY 2023)
- Ebitda -15.74%
(FY 2023)
- Net Worth 14.58%
(FY 2023)
- Total Assets 19.62%
(FY 2023)
About Bmw Pharmaco India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.36 Cr. The company has closed loans amounting to ₹5.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Madhwani and Divya Madhwani serve as directors at the Company.
- CIN/LLPIN
U24233MP2006PTC018879
- Company No.
018879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bmw Pharmaco India Private Limited offer?
Bmw Pharmaco India Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Digestive System Drugs & Medicines, Antispasmodic Drugs, Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Bmw Pharmaco India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Madhwani  | Director | 21-Aug-2006 | Current |
| Divya Madhwani | Additional Director | 13-May-2021 | Current |
Financial Performance of Bmw Pharmaco India.
Bmw Pharmaco India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.31% decrease. The company also saw a substantial fall in profitability, with a 39.64% decrease in profit. The company's net worth Soared by an impressive increase of 14.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bmw Pharmaco India?
In 2023, Bmw Pharmaco India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Feb 2020 | ₹9.36 Cr | Open |
Hdfc Bank Limited Creation Date: 25 Nov 2011 | ₹2.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 25 Nov 2011 | ₹3.74 Cr | Satisfied |
How Many Employees Work at Bmw Pharmaco India?
Bmw Pharmaco India has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bmw Pharmaco India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bmw Pharmaco India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
